Page 85 - girbes

REFERENCIAS

Agrawal, B. y Goldstein, I. (1965). Specific binding of concanavalin A to
cross-linked dextran gels. Biochem. J., 96: 23c-25c.
Akbari, B., Farajnia, S., Khosroshahi, S.A., Safari, F., Yousefi, M.,
Dariushnejad, H. y Rahbarnia, L. (2017). Immunotoxins in cancer
therapy: Review and update. Int Rev Immunol., 36: 207-219.

Alavi M, Hamidi M. (2019). Passive and active targeting in cancer therapy
by liposomes and lipid nanoparticles. Drug Metab Pers Ther., 34(1). doi:
10.1515/dmpt-2018-0032.

Almkvist, J. y Karlsson, A. (2004). Galectins as inflammatory mediators.
Glycoconjugate J. 19: 575–581.

An, H., Kronewitter, S., de Leoz, M. y Lebrilla, C. (2009). Glycomics and
disease markers. Curr. Opin. Chem. Biol., 13: 601-607.

Ardelean, I., Ficai. D., Sonmez, M., Oprea, O., Nechifor, G., Andronescu,
E., Ficai, A. y Titu, M. (2019). Hybrid magnetic nanostructures for cancer
diagnosis and therapy. Anticancer Agents Med Chem., 19: 6-16.

Barbieri, L., Battelli, M. y Stirpe, F. (1993). Ribosome-inactivating proteins
from plants. Biochim. Biophys. Acta, 1154: 237-282.

Barbieri, L., Ciani, M., Girbés, T., Liu, W., Van Damme, E., Peumans, W.
y Stirpe, F. (2004) Enzymatic activity of toxic and non-toxic type 2
ribosome-inactivating proteins. FEBS Lett., 563: 219-222.

Barondes, S., Cooper, D., Gitt, M. y Leffler, H. (1994) Galectins. Structure
and function of a large family of animal lectins. J. Biol.Chem., 269: 20807-
20810.

Barriuso, B., Antolin, P., Arias, F., Girotti, A., Jiménez, P., Córdoba-Díaz,
M., Córdoba-Díaz, D. y Girbes, T. (2016). Anti-Human Endoglin (hCD105)
Immunotoxin-Containing Recombinant Single Chain RibosomeInactivating
Protein Musarmin 1. Toxins, 8(6): art. 184.
Battelli, M., Citores, L., Buonamici, L, Ferreras, J., M. de Benito, F., Stirpe,
F. y Girbés, T. (1997). Toxicity and cytotoxicity of nigrin b, a two-chain

83